News

Findings from a recent study in mice suggest that neonatal colonization of gut microbiota influences generalized autoimmunity in adult life, which may have implications for conditions such as Systemic Lupus Erythematosus. Researchers from Ghent University Hospital in Belgium found that upon increased levels of segmented filamentous bacteria, an alteration in…

In a new study entitled “Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN,” researchers discovered a key pathway that protects healthy tissue against an exacerbated and deleterious immune response. The study was published in the Journal of the American…

A research team from the University Hospital Hamburg Eppendorf in Germany recently discovered an important pathway that may protect healthy tissue from immune responses. These findings can potentially help doctors provide better treatments for patients with autoimmune conditions such as Lupus. The immune system responds to inflammation by over-activation in…

A research team from the University of Dundee recently discovered that a mutation in the protein ABIN1 mediates chronic inflammation and is associated with the development of cardiovascular disease. The results, which have important clinical applications for chronic inflammatory conditions such as systemic lupus erythematous (SLE) and rheumatoid arthritis…

A recent study entitled “Electrocardiographic Findings in Systemic Lupus Erythematosus: Data From an International Inception Cohort” revealed that systemic lupus erythematosus (SLE) patients also suffer from cardiac anomalies. In the study, published in the journal Arthritis Care & Research, electrocardiographic methods were applied…

Applications for a series of grants from the National Research Program of the Lupus Foundation of America are currently open for investigators working on lupus-related research. The program is intended to fund critical areas of lupus scientific research, such as environmental triggers of the disease and health…

A new project is being launched by George Freeman MP, the British Parliamentary Under Secretary of State for Life Sciences in collaboration with several academic facilities and industry partners to improve treatment of systemic lupus erythematosus (SLE) in the UK. The MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified…

UBM Medica US, a company that delivers integrated and strategic communications solutions, recently announced that Rheumatology Network, an online network dedicated to rheumatologists, will feature a debate with experts on the barriers to investigation into new treatments for rheumatic diseases such as lupus. The topic is based on an article…